Becton, Dickinson And Co.

NYSE:BDX   3:59:55 PM EDT
+5.30 (+2.15%)

FDA Says BD Announces Voluntary Recall On Intraosseous Products

Published: 06/23/2022 00:03 GMT
Becton, Dickinson And Co. (BDX) - FDA Says Bd Announces Voluntary Recall on Intraosseous Products.
FDA: Bd's Product Issues May Result in Delays in Care Due to Limited Or Non-functioning Intraosseous Access Or Could Also Lead to Needlestick Injuries.